[16] Additionally, rapid weight loss can temporarily disrupt hormonal balance, and the FDA recommends discontinuing Zepbound at least two months before a planned pregnancy due to limited safety data in pregnant individuals
#obesitymedicine #glp1 #metabolichealth #semaglutide #weightmanagement GLP-1 vs GIP vs Dual Agonist Medications for Obesity GLP-1, GIP, and dual agonist medications are all part of the incretin class
The company has not publicly disclosed specific programs targeting oral tirzepatide delivery, but given the enormous commercial incentive and ongoing advances in oral peptide technology, it would be surprising if they were not exploring the possibility
Using a dull needle or reusing needles can also make bruising more likely
After reaching your target weight on a standard dose, gradually titrate down to the lowest dose that maintains your results
For Wegovy, the FDA approves three maintenance options: 2.4 mg weekly the standard maintenance dose used in the STEP 1 and STEP 5 trials